Loading...
NPI 1104812528 · Chicago, IL · Infectious Disease Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Wahab Brobbey is a infectious disease physician provider located in Chicago, Illinois. This profile covers 22 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Wahab Brobbey |
| Address | 2923 N California Ave |
| City | Chicago |
| State | IL |
| ZIP | 60618 |
| Taxonomy | Infectious Disease Physician |
| NPI Enumerated | September 21, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1M |
| Medicaid | $100.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 11,750 | $40 | $423.1K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 1,670 | $100 | $161.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,970 | $30 | $155.3K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 480 | $140 | $67.3K |
| J1306 | Injection, inclisiran, 1 mg | 7,380 | $10 | $66.5K |
| J0897 | Injection, denosumab, 1 mg | 2,820 | $20 | $50.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 560 | $50 | $26.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $100 | $25.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 160 | $70 | $10.7K |
| 99222 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 80 | $110 | $8.6K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J1569 | 2 | 50 | 2,730 | $40 | $143K |
| J0897 | 178 | 410 | 2,520 | $20 | $90.8K |
| J1306 | 10 | 20 | 7,380 | $10 | $86.6K |
| J1745 | 8 | 60 | 2,170 | $30 | $85.1K |
| 96413 | 88 | 370 | 130 | $100 | $19.3K |
| 99233 | 22 | 5,990 | 100 | $100 | $18.7K |
| 99214 | 10,883 | 18,540 | 110 | $80 | $17.1K |
| 99232 | 6,003 | 7,960 | 90 | $60 | $12.4K |
| 99223 | 39 | 6,190 | 50 | $140 | $10.4K |
| 99213 | 4,611 | 17,390 | 70 | $60 | $8.8K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 2,130 | $40 | $83.1K |
| 99255 | The provider sees a patient for an inpatient or observation consultation involving evaluation and management (E/M). The E/M involves a high level of medical decision making or the provider spends at… | 150 | $80 | $12K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 50 | $50 | $2.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 90 | $20 | $1.5K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 70 | $20 | $1.3K |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 116 | 150 | 170 | $50 | $39.9K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 319 | 3,830 | 210 | $40 | $29.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 49 | 80 | 150 | $40 | $29.3K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 1,194 | 2,460 | 60 | $70 | $18.1K |
| 99255 | The provider sees a patient for an inpatient or observation consultation involving evaluation and management (E/M). The E/M involves a high level of medical decision making or the provider spends at… | 70 | 300 | 40 | $80 | $14.4K |
Other providers in the same ZIP code as Wahab Brobbey, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| The Thresholds | IL | Mental Health Clinic/Center (Including Community Mental Health Center) | $0 | $4.9M |
| Ghassan Aswad | IL | Pediatrics Physician | $0 | $3.8M |
| Mensur Sunje | IL | Phlebology Physician | $199.9K | $2.3M |
| Vishnu Chundi | IL | Infectious Disease Physician | $978.9K | $354.9K |
| David Hines | IL | Infectious Disease Physician | $948.7K | $271.7K |
| Bogdan Derylo | IL | Nephrology Physician | $846.4K | $64K |
| Ireneusz Pawlowski | IL | Internal Medicine Physician | $332.7K | $13.7K |
| Mark Leischner | IL | Nephrology Physician | $240K | $68.7K |
| Jeffrey Ackerman | IL | Orthopaedic Surgery Physician | $200.8K | $1.6K |
| Julio Arnau Gonzalez | IL | Family Medicine Physician | $45.8K | $117.2K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.